Citations

Clear

4847 citation(s) found for "Tu, Eric".

Two Cases of Early Childhood Selective Mutism
Ale, Chelsea M. , Mann, Angela , Menzel, Jessie E. , Lewin, Adam B. , Storch, Eric A.

Mayo Clinic

Clinical Case Studies | April 10, 2013 | Volume: 12 | Issue: 4 | Pages: 278-290

10.1177/1534650113482358 Get It

Selective Mutism (SM) is a highly impairing disorder which typically presents upon entry to school and affects approximately 0.7% of children. Despite its impact on social and academic development, it is a difficult disorder to treat and there is a small evidence base for behavioral treatment. Preliminary evidence suggests that behavioral treatment focused on exposure to social interactions, social skill building, and involvement of caregivers in treatment may be promising. This article presents two cases of early childhood SM to demonstrate the importance of tailored treatment implementation to meet the individual needs of each family and help children resume typical social development.
Cytokine Production at the Site of Disease in Chronic Eosinophilic Pneumonitis
Kita, H., Sur, Sanjiv , Hunt, Loren W., Edell, Eric S. , Weiler, Deborah A., Swanson, Mark C., Samsel, R. W., Abrams, J S, Gleich, Gerald J. , Kita, Hirohito , Kita, H

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 153 | Issue: 4 | Pages: 1437-1441

10.1164/ajrccm.153.4.8616578 | PMID 8616578 Get It

Abstract Chronic eosinophilic pneumonitis (CEP) is characterized by longstanding respiratory symptoms accompanied by a massive pulmonary eosinophil infiltration. We hypothesized that cytokine(s) produced in the disease sites are implicated in the pathophysiology of CEP. We studied peripheral blood and bronchoalveolar lavage fluids (BALF) obtained from two lung segments of a patient with CEP. Seventy times more eosinophils were found in the BALF from an involved lung segment (showing patchy opacification on a chest roentgenogram) than from an uninvolved segment. The eosinophil-active cytokines interleukin-5 (IL-5), IL-6, and IL-10 were strikingly elevated in the BALF from the involved lung segment, whereas no or minimal levels of these cytokines were detectable in the BALF from the uninvolved segment or serum, respectively. Leukocytes in the involved lung segment, but not those in peripheral blood, expressed messenger ribonucleic acid (mRNA) for IL-5, IL-6, and IL-10. In contrast, IL-2, IL-3, IL-4, interferon-gamma (IFN-gamma), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha) were not detected in any sample. These findings suggest that increased production of several cytokines, such as IL-5, IL-6, and IL-10, in the involved lung segment, but not in the uninvolved lung segment or peripheral blood, is a critical pathophysiologic feature of CEP.
Tracheobronchial Involvement in Wegener's Granulomatosis
Daum, Timothy E., Specks, U., Colby, Thomas V. , Edell, Eric S. , Brutinel, M., Prakash, Udaya B. S., DeRemee, Richard A., Specks, Ulrich

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 151 | Issue: 2 | Pages: 522-526

10.1164/ajrccm.151.2.7842215 | PMID 7842215 Get It

Abstract This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59%) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17%), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60%), tracheal or bronchial stenosis without inflammation in four (13%), and hemorrhage without identifiable source in two (4%) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody titers reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.
Resolution of Chylous Pulmonary Congestion and Respiratory Failure in Lymphangioleiomyomatosis with Sirolimus Therapy
Moua, Teng , Olson, Eric J. , Jean, Hope C. St., Ryu, Jay H.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 186 | Issue: 4 | Pages: 389-390

10.1164/ajrccm.186.4.389 | PMID 22896596 Get It

Association of diabetes with amnestic and nonamnestic mild cognitive impairment
Roberts, Rosebud O., Geda, Yonas E. , Cha, Ruth H., Baertlein, Luke , Tangalos, Eric G., Ivnik, Robert J., Mielke, Michelle M. , Petersen, Ronald C. , Knopman, David S. , Cha, Ruth H., Pankratz, V. Shane , Boeve, Bradley F. , Mielke, Michelle M , Geda, Yonas E

Mayo Clinic

Alzheimer's & Dementia | April 4, 2013 | Volume: 10 | Issue: 1 | Pages: 18-26

10.1016/j.jalz.2013.01.001 | PMID 23562428 Get It

AbstractBackgroundType 2 diabetes may increase the risk of amnestic mild cognitive impairment (aMCI) through Alzheimer's disease (AD)‐related and vascular pathology and may also increase the risk of nonamnestic MCI (naMCI) through vascular disease mechanisms. We examined the association of type 2 diabetes with mild cognitive impairment (MCI) and MCI subtype (aMCI and naMCI) overall and by sex.MethodsParticipants were Olmsted County, Minnesota residents (70 years and older) enrolled in a prospective, population‐based study. At baseline and every 15 months thereafter, participants were evaluated using the Clinical Dementia Rating scale, a neurological evaluation, and neuropsychological testing for a diagnosis of normal cognition, MCI, and dementia by a consensus panel. Type 2 diabetes was ascertained from the medical records of participants at baseline.ResultsOver a median 4.0 years of follow‐up, 348 of 1450 subjects developed MCI. Type 2 diabetes was associated (hazard ratio [95% confidence interval]) with MCI (1.39 [1.08–1.79]), aMCI (1.58 [1.17–2.15]; multiple domain: 1.58 [1.01–2.47]; single domain: 1.49 [1.09–2.05]), and the hazard ratio for naMCI was elevated (1.37 [0.84–2.24]). Diabetes was strongly associated with multiple‐domain aMCI in men (2.42 [1.31–4.48]) and an elevated risk of multiple domain naMCI in men (2.11 [0.70–6.33]), and with single domain naMCI in women (2.32 [1.04–5.20]).ConclusionsDiabetes was associated with an increased risk of MCI in elderly persons. The association of diabetes with MCI may vary with subtype, number of domains, and sex. Prevention and control of diabetes may reduce the risk of MCI and Alzheimer's disease.
Subjective cognitive decline: Self and informant comparisons
Caselli, Richard J. , Chen, Kewei , Locke, Dona E.C. , Lee, Wendy , Roontiva, Auttawut, Bandy, Dan, Fleisher, Adam , Reiman, Eric M. , Locke, Dona E C

Mayo Clinic

Alzheimer's & Dementia | April 4, 2013 | Volume: 10 | Issue: 1 | Pages: 93-98

10.1016/j.jalz.2013.01.003 | PMID 23562429 Get It

AbstractBackgroundIt is unclear whether self‐ or informant‐based subjective cognition better distinguishes emotional factors from early‐stage Alzheimer's disease (AD).MethodsHealthy members (n = 447) of the Arizona apolipoprotein E (APOE) cohort and their informants completed the self and informant paired Multidimensional Assessment of Neurodegenerative Symptoms questionnaire (MANS).ResultsDecline on the MANS was endorsed by 30.6% of members and 26.2% of informants. Self‐ and informant‐based decliners had higher scores of psychological distress and slightly lower cognitive scores than nondecliners. Over the next 6.7 years, 20 developed mild cognitive impairment (MCI). Converters were older at entry than nonconverters (63.8 [7.0] vs 58.8 [7.3] years, P = .003), 85% were APOE ε4 carriers (P < .0001), and they self‐endorsed decline earlier than informants (58.9 [39.2] vs 28.0 [40.4] months before MCI; P = .002).ConclusionsSelf‐ and informant‐based subjective decline correlated with greater psychological distress and slightly lower cognitive performance. Those with incident MCI generally self‐endorsed decline earlier than informants.
Brief Report: Rheumatoid Arthritis Is Associated With Left Ventricular Concentric Remodeling: Results of a Population‐Based Cross‐Sectional Study
Davis, John M. , Crowson, Cynthia S. , Roger, Véronique L. , Karon, Barry L., Borgeson, Daniel D., Therneau, Terry M. , Matteson, Eric L. , Rodeheffer, Richard J. , Gabriel, Sherine E., Myasoedova, Elena , Davis, John M

Mayo Clinic

Arthritis & Rheumatism | April 1, 2013 | Volume: 65 | Issue: 7 | Pages: 1713-1718

10.1002/art.37949 | PMID 23553738 Get It

ObjectiveTo study left ventricular (LV) geometry in patients with rheumatoid arthritis (RA) and no history of heart failure compared with that in subjects with neither RA nor a history of heart failure, and to determine the impact of RA on LV remodeling.MethodsA cross‐sectional, community‐based study was conducted among adult (age ≥50 years) patients with RA and age‐ and sex‐matched subjects with neither RA nor a history of heart failure. All participants underwent standard 2‐dimensional Doppler echocardiography. LV geometry was classified into the following 4 categories based on relative wall thickness and sex‐specific cutoffs for the LV mass index: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, or normal geometry.ResultsAmong 200 patients with RA and 600 age‐ and sex‐matched subjects without RA, the mean age was 65 years, and 74% of the individuals in both cohorts were female. Compared with subjects without RA, patients with RA were significantly more likely to have abnormal LV geometry (odds ratio [OR] 1.44, 95% confidence interval [95% CI] 1.03–2.00), even after adjusting for cardiovascular risk factors and comorbidities. Among subjects with abnormal LV geometry, the odds of concentric LV remodeling were significantly increased in patients with RA (OR 4.73, 95% CI 2.85–7.83). In linear regression analyses, the LV mass index appeared to be lower in patients with RA who were currently receiving corticosteroids (β ± SE −0.082 ± 0.027, P = 0.002), even after adjusting for cardiovascular risk factors and comorbidities.ConclusionRA was strongly associated with abnormal LV remodeling (particularly concentric LV remodeling) among RA patients without heart failure. This association remained significant after adjustment for cardiovascular risk factors and comorbidities. RA disease–related factors may promote changes in LV geometry. The biologic mechanisms underlying LV remodeling warrant further investigation.
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions
Burns, Christine , Chen, Kewei , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M.

Mayo Clinic

Neurology | March 28, 2013 | Volume: 80 | Issue: 17 | Pages: 1557-1564

10.1212/wnl.0b013e31828f17de | PMID 23535495 Get It

The neuropsychology of normal aging and preclinical Alzheimer's disease
Caselli, Richard J. , Locke, Dona E.C. , Dueck, Amylou C. , Woodruff, Bryan K. , Hoffman‐Snyder, Charlene , Rademakers, Rosa , Fleisher, Adam , Reiman, Eric M. , Knopman, David S. , Dueck, A. C. , Locke, Dona E C

Mayo Clinic

Alzheimer's & Dementia | March 26, 2013 | Volume: 10 | Issue: 1 | Pages: 84-92

10.1016/j.jalz.2013.01.004 | PMID 23541188 Get It

AbstractObjectiveA National Institute on Aging–sponsored work group on preclinical Alzheimer's disease (AD) articulated the need to characterize cognitive differences between normal aging and preclinical AD.MethodsSeventy‐one apolipoprotein E (APOE) ε4 homozygotes, 194 ε3/ε4 heterozygotes, and 356 ε4 noncarriers age 21 to 87 years who were cognitively healthy underwent neuropsychological testing every 2 years. Longitudinal trajectories of test scores were compared between APOE subgroups.ResultsThere was a significant effect of age on all cognitive domains in both APOE ε4 carriers and noncarriers. A significant effect of APOE ε4 gene dose was confined to the memory domain and the Dementia Rating Scale. Cross‐sectional comparisons did not discriminate the groups.ConclusionsAlthough cognitive aging patterns are similar in APOE ε4 carriers and noncarriers, preclinical AD is characterized by a significant ε4 gene dose effect that impacts memory and is detectable longitudinally. Preclinical neuropsychological testing strategies should emphasize memory‐sensitive measures and longitudinal design.
Effect of Prior Radiotherapy and Ablative Therapy on Surgical Outcomes for the Treatment of Rectourethral Fistulas
Linder, Brian J. , Umbreit, Eric , Dozois, Eric J. , Thapa, Prabin , Elliott, Daniel S. , Larson, David W. , Linder, Brian J

Mayo Clinic

Journal of Urology | March 26, 2013 | Volume: 190 | Issue: 4 | Pages: 1287-1291

10.1016/j.juro.2013.03.077 | PMID 23538238 Get It